Research Article

TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population

Table 5

TSP-1-1223 A/G polymorphism and clinicopathological characteristics in patients with bladder cancer.

Clinicopathological characteristicsGenotypes (%) Adjusted OR (95% CI)a
AA + AGGG

Tumor stage
 Nonmuscle invasive407 (87.3) 59 (12.7)1.00 (reference)
 Muscle invasive125 (87.4) 18 (12.6)0.9791.01 (0.57–1.78)
Tumor grade
 Grade 1264 (88.6) 34 (11.4)1.00 (reference)
 Grade 2168 (86.6) 26 (13.4)0.4401.26 (0.71–2.23)
 Grade 3100 (85.5) 17 (14.5)0.2941.43 (0.73–2.79)
Number
 Single384 (88.1) 52 (11.9)1.00 (reference)
 Multiple148 (85.5) 25 (14.5)0.4331.23 (0.73–2.07)
Size
 <3 cm345 (88.2) 46 (11.8)1.00 (reference)
 ≥3 cm187 (85.8) 31 (14.2)0.3671.24 (0.74–2.08)

CI: confidence interval; OR: odds ratio.
Adjusted for age, gender, smoking, drinking status, and family history of cancer in logistic regression model.